🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 2 clinical trial will evaluate the safety and immunogenicity of ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2022-03-30
Trial ID
NCT05289037
Treatments Being Tested
The main purpose of this study is to assess the ability of H5 influenza vir...
Status
Completed
Location
Optimal Research
Start Date
2018-03-15
Trial ID
NCT03497845
Treatments Being Tested
Study to evaluate the safety and immunogenicity of H7N9 antigen in combinat...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-03-16
Trial ID
NCT04789577
This is a Phase I randomized, double-blind, controlled trial in 275 males a...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-08-16
Trial ID
NCT02624219
Treatments Being Tested
This is a randomized, double blind, placebo controlled, first-in-human (FIH...
Status
Completed
Location
Linear Clinical Research Ltd
Start Date
2020-06-19
Trial ID
NCT04405908
The purpose of this study is to see how the body reacts to different streng...
Status
Completed
Location
Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases
Start Date
2009-09
Trial ID
NCT00963157
Treatments Being Tested
Background: \- Adjuvants are substances included in vaccines that stimulat...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-03-20
Trial ID
NCT01578317
Treatments Being Tested
This is a randomized, un-blinded, Phase II study in males and non-pregnant ...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Alabama Vaccine Research Clinic
Start Date
2018-02-20
Trial ID
NCT03318315
This study is conducted to assess safety and immunogenicity of GSK's HBsAg ...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-04
Trial ID
NCT05561673
Treatments Being Tested
Approximately 216, and up to 240, healthy males and non-pregnant females, 1...
Status
Completed
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Start Date
2011-05
Trial ID
NCT01317758
Treatments Being Tested